SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-071093
Filing Date
2024-06-10
Accepted
2024-06-10 09:05:13
Documents
20
Period of Report
2024-06-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20240610.htm   iXBRL 8-K 60926
2 EX-99.1 lbph-ex99_1.htm EX-99.1 29822
3 EX-99.2 lbph-ex99_2.htm EX-99.2 8028
4 PDF COURTESY COPY lbph-ex99_2.pdf EX-99.2 549082
5 GRAPHIC img58896055_0.jpg GRAPHIC 11946
6 GRAPHIC lbph-ex99_2s1.jpg GRAPHIC 349297
7 GRAPHIC lbph-ex99_2s2.jpg GRAPHIC 767008
8 GRAPHIC lbph-ex99_2s3.jpg GRAPHIC 341385
9 GRAPHIC lbph-ex99_2s4.jpg GRAPHIC 258010
10 GRAPHIC lbph-ex99_2s5.jpg GRAPHIC 320248
  Complete submission text file 0000950170-24-071093.txt   3811630

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lbph-20240610.xsd EX-101.SCH 32723
23 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20240610_htm.xml XML 5112
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 241031585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)